Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 15, Number 10—October 2009

Community-Associated Methicillin-Resistant Staphylococcus aureus, Iowa, USA

Philip Van De Griend, Loreen A. HerwaldtComments to Author , Bret Alvis, Mary DeMartino, Kristopher Heilmann, Gary Doern, Patricia Winokur, Diana DeSalvo Vonstein, and Daniel Diekema
Author affiliations: The University of Iowa Carver College of Medicine, Iowa City, Iowa, USA (P. Van De Griend, L.A. Herwaldt, B. Alvis, K. Heilmann, G. Doern, P. Winokur, D. Diekema); The University of Iowa Hygienic Lab, Iowa City (M. DeMartino); The University of Iowa College of Public Health, Iowa City (L.A. Herwaldt); The University of Iowa Hospitals and Clinics, Iowa City (L.a. Herwaldt, D. Diekema); The Iowa City Veterans Administration Medical Center, Iowa City (P. Winokur, D.D. Vonstein, D. Diekema)

Main Article

Table 3

Antimicrobial drug susceptibility of 54 invasive MRSA USA300/400 isolates, Iowa, USA, 2006*

Antimicrobial agent % Susceptible
Erythromycin 9
Levofloxacin 57
Clindamycin† 93
Tetracycline 93
Mupirocin 98
Rifampin 98
Trimethoprim/sulfamethoxazole 100
Vancomycin 100
Gentamicin 100
Daptomycin 100
Linezolid 100

*MRSA, methicillin-resistant Staphylococcus aureus.
†Includes D-testing of all erythromycin-resistant, clindamycin-susceptible isolates.

Main Article

Page created: September 24, 2012
Page updated: September 24, 2012
Page reviewed: September 24, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.